Our people
What we do
Sectors Practices Legal Tech

Aerospace and Defense

Automotive and Mobility

Consumer

Education

Energy

Financial Institutions

Insurance

Life Sciences and Health Care

Manufacturing and Industrials

Private Capital

Real Estate

Sports, Media and Entertainment

Technology

Transportation and Logistics

Corporate & Finance

Disputes

Intellectual Property

Regulatory
Case studies
Our thinking
All Our thinking

Comparative guides

Digital Client Solutions

Events and webinars

Podcasts

News

Trump Administration Executive Order (EO) Tracker
ESG
Careers

Eng

Deutsch
English
Español
Français
日本語
中文

Eng

Deutsch
English
Español
Français
日本語
中文

False

Our people
What we do
Sectors

Aerospace and Defense

Automotive and Mobility

Consumer

Education

Energy

Financial Institutions

Insurance

Life Sciences and Health Care

Manufacturing and Industrials

Private Capital

Real Estate

Sports, Media and Entertainment

Technology

Transportation and Logistics

Practices

Corporate & Finance

Disputes

Intellectual Property

Regulatory

Legal Tech

Aerospace and Defense

Automotive and Mobility

Consumer

Education

Energy

Financial Institutions

Insurance

Life Sciences and Health Care

Manufacturing and Industrials

Private Capital

Real Estate

Sports, Media and Entertainment

Technology

Transportation and Logistics

Corporate & Finance

Disputes

Intellectual Property

Regulatory
Case studies
Our thinking
All Our thinking

Comparative guides

Digital Client Solutions

Events and webinars

Podcasts

News

Trump Administration Executive Order (EO) Tracker
ESG
Careers

About us
Where we are
Media center
Responsible Business
HL Inclusion
Alumni

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Back to Our thinking

Topics

Global Market Issues
Administrative and Public Law
Aerospace and Defense
Antitrust and Competition
Automotive and Mobility
Banking and Loan Finance
Business and Human Rights
Capital Markets
Construction and Engineering
Consumer
Corporate Governance / Public Company Advisory / Company Law
Data, Privacy and Cybersecurity
Education
Employment
Energy and Natural Resources
Environment
Esports and Gaming
Executive Compensation, Employee Benefits and Share Incentives
Financial Services
Food and Beverage
Gaming and Gambling Law
Government Contracts and Public Procurement
Government Relations
Health Regulatory
Infrastructure, Energy, Resources and Projects
Insurance / re-insurance
Intellectual Property
International Arbitration
International Trade and Investment
Investigations, White Collar and Fraud
Leveraged and Acquisition Finance
Life Sciences and Health Care
Manufacturing and Industrials
Media and Entertainment
Medical Device and Technology Regulatory
Mergers and Acquisitions
Pensions
Pharmaceuticals and Biotechnology Regulatory
Private Capital
Private Equity, Venture Capital and Investment Funds
Products Law
Real Estate
REITs
Restructuring and Special Situations
Risks, Disputes, and Litigation
Space and Satellite
Sports
Strategic Operations, Agreements and Regulation
Sustainable Finance
Tax
Technology
Telecommunications and Internet
Transfer Pricing
Transportation and Logistics
Artificial Intelligence
Brexit
COVID-19
Digital Transformation
Digital Services Act and Digital Markets Act
ESG, Sustainability, and Climate
EU Green Deal
Federal Trade Commission (FTC)
Foreign Direct Investment
Inflation Reduction Act
Russia sanctions
Supply Chain
UK2030
Commercial Human Rights
Constitutional Law
Freedom of Information
Judicial Review
Public Law
Competition Litigation and Disputes
Derivatives and Structured Products
Equity Capital Markets
General Debt Capital Markets
High Yield
Securitization and Structured Finance
Trust and Agency
E-Commerce
Electronics and Consumer Appliances
Retail and Fashion
Energy Transition
Hydrogen
Mining
Nuclear
Oil, Gas and LNG
Power, renewables and alternative energy
Environmental Compliance, Litigation and Internal Investigations
Banking Products
Consumer Finance
Digital Assets and Blockchain
Financial Crime including Anti-money Laundering
Financial Services Litigation and Disputes
Financial Services Privacy
Financial Services Regulatory Investigations and Enforcement
Financial Services Securities and Markets Regulation
FinTech
Funds and Asset Management
Open Banking
Payments
Prudential Regulation
Gaming and Gambling Related Payments Services
Online Gaming and Gambling
Congressional Oversight and Investigation
Devolution and devolved administrations
Federal Funding and Appropriations
Legislation and Policy Engagement and Development
Political Law Compliance
Public Policy and Regulation
Sovereign Government Relations and Public Affairs
State,Local Government Representation and Policy
UK Parliamentary Affairs
Coverage and Reimbursement
Drug Pricing and Government Reporting
Health Compliance, Fraud and Abuse
Health Insurance Plans and Managed Care
Health Policy and Advocacy
Health Privacy
Copyright
Designs
Domain Names
IP and Technology Transactions
Patents
Trademarks and Brands
Trade Secrets and Confidential Know-how
Unfair Competition
Bribery and Corruption
False Claims Act
Financial Crime
Investigations, Regulatory and Compliance
Whistleblowing
Cell, Tissue, and Gene Therapies (CTGT)
Clinical Trials
Combination Products
Digital Health
Emerging Companies and Investors
Hospitals and Health Care Providers
Licensing and Commercial Transactions
Life Science Government Enforcement and Compliance
Chemicals and Industrial Products and Services
Conglomerates
Advertising and Promotion of Medical Devices
Clinical Studies Product Design and Development
Conformity Assessment Procedure,CE Mark
In Vitro Diagnostics
Joint Ventures and Strategic Alliances
MDR,IVDR
Medical Device Software and Cybersecurity
Postmarket Performance
Premarket Strategy, Submissions, and Review
Regulatory Inspections and QSR-ISO 13485
State Licensing of Medical Device
Joint Ventures and Strategic Alliances
Advertising and Promotion of Pharmaceuticals and Biotechnology
Biologics and Biosimilars
Controlled Substances
Life Cycle Management of Pharmaceuticals and Biotechnology
OTC Drugs and Cosmetics
Regulatory Exclusivities, Hatch-Waxman, and Similar Statutes
Regulatory Inspections and cGMP
Fund Formation, Fund Raising, Restructuring and Dissolution
Infrastructure and Energy Funds
Investments, Financing, Portfolio Company Advice and Exits
Pension Funds
Private Capital Regulatory, Compliance and Disputes
Private Credit-Debt Funds
Private Equity Funds
Real Estate Investment Vehicles and Funds
Sovereign Wealth Funds
Venture Capital Funds
Fund Formation, Fund Raising, Restructuring and Dissolution
Management Incentive Programs
Private Equity Transactions
Secondaries
Venture Capital Transactions
Cross-border Real Estate
Development, Planning and Land Use
ESG in Real Estate
Hotels and Leisure
Real Estate Investment Vehicles and Funds
Real Estate Disputes
Real Estate Finance
Business Restructuring and Insolvency Litigation
Class Actions and Group Actions
Competition Litigation and Disputes
Corporate and Securities Litigation
Crisis Management
Financial Services Litigation and Disputes
Global Asset Recovery and Enforcement
Real Estate Disputes
Sovereign Asset Recovery
Technology Litigation and Disputes
U.S. Appellate and Supreme Court Litigation
Commercial Law and Contracts
Logistics
Mobility
Rail
Shipping
Uncrewed Aircraft Systems-Advanced Air Mobility-Drone Security

Countries

Australia
Belgium
Brazil
France
Germany
Hong Kong
Hungary
Indonesia
Ireland
Italy
Japan
Luxembourg
Mexico
Netherlands
People's Republic of China
Poland
Saudi Arabia
Singapore
South Africa
South Korea
Spain
United Arab Emirates
United Kingdom
United States
Vietnam

Language

English
中文
Deutsch
Español
Français
日本語
Português

Date

All publications
Within 30 days
Within 3 months
Within 1 year
Within 2 years

Clear

608 results

Life Sciences and Health Care
English

No results found

News

AI Health Law & Policy: FDA’s rapidly evolving regulatory paradigms

09 四月 2025

News

Reissued patents get Hatch-Waxman PTE based on original patent date, CAFC rules

08 四月 2025

News

FDA Reduction-In-Force expected to impact drug & biologic review and regulation, other operations

02 四月 2025

News

Federal court vacates FDA Laboratory Developed Test rule

01 四月 2025

News

PRODUCT | PFAS and product law: Navigating regulatory and legal risks

31 三月 2025

News

HHS plans for workforce reduction may impact FDA operations

27 三月 2025

News

The European Commission tackles shortages of critical medicines through the Critical Medicines Act

27 三月 2025

News

State Licensing Spotlight – Medical Device Manufacturers & Distributors: Compliance Strategies for Avoiding or Reducing Penalties

24 三月 2025

Insights and Analysis

Early benefit assessment of medicinal products in Germany – first adaptions to AMNOG implementing the EU HTA Regulation

18 三月 2025

News

State Licensing Spotlight – Prescription Medical Device Manufacturers & Distributors: Enforcement and penalties for operating without a license

17 三月 2025

News

Center for Medicare and Medicaid innovation (CMMI) to end four payment models in cost-cutting effort

15 三月 2025

Insights and Analysis

Pharmaceutical and cosmetic companies targeted by revised urban wastewater treatment directive – A critical moment to assess legal recourse under EU law?

14 三月 2025

Digital Client Solutions

Empowering you to lead change through our digital solutions.

Learn more

Quick Links

About us
Careers
Case studies
Contact us
HL Inclusion
Our people
Our thinking
Responsible Business

Cookies
Disclaimer
Fraudulent and Scam Emails
Legal notices
Modern Slavery Statement
Our thinking terms of use
Privacy
RSS

Connect with us

Stay in the know

© 2025 Hogan Lovells. All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses, each of which is a separate legal entity. Attorney advertising. Prior results do not guarantee a similar outcome.

Subscribe to Our thinking

Connect with us